Transgenic mice lacking white fat: Models for understanding human lipoatrophic diabetes

被引:55
作者
Reitman, ML
Mason, MM
Moitra, J
Gavrilova, O
Marcus-Samuels, B
Eckhaus, M
Vinson, C
机构
[1] NIDDKD, Diabet Branch, Bethesda, MD 20892 USA
[2] NCI, Biochem Lab, Bethesda, MD 20892 USA
[3] NIH, Vet Resources Program, Off Res Serv, Bethesda, MD 20892 USA
来源
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS | 1999年 / 892卷
关键词
D O I
10.1111/j.1749-6632.1999.tb07802.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human disease lipoatrophic (or lipodystrophic) diabetes is a rare syndrome in which a deficiency of adipose tissue is associated with Type 2 diabetes. This disease is an interesting contrast to the usual situation in which diabetes is associated with obesity, an excess of fat. Aside from obesity, patients with lipodystrophic diabetes have the other features associated with Metabolic Syndrome X, including hypertension and dyslipidemia. The contrast between diabetes,vith a lack of fat and diabetes,vith an excess of fat provides an opportunity to study the mechanisms causing Type 2 diabetes and its complications. Recently, three laboratories have produced transgenic mice that are deficient in white adipose tissue. These mice have insulin resistance and other features of lipoatrophic diabetes, and are a faithful model for the human disease. Here we review the different murine models of fat ablation and compare the murine and human diseases, addressing the questions: Is the lack of fat causative of the diabetes, and if so by what mechanism? How could the other clinical features be explained mechanistically? And finally, what can be gleaned about insight into treatment options?
引用
收藏
页码:289 / 296
页数:8
相关论文
共 26 条
[1]  
ASHAR HR, 1995, CELL, V82, P57
[2]   Troglitazone action is independent of adipose tissue [J].
Burant, CF ;
Sreenan, S ;
Hirano, KI ;
Tai, TAC ;
Lohmiller, J ;
Lukens, J ;
Davidson, NO ;
Ross, S ;
Graves, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2900-2908
[3]   The search for human obesity genes [J].
Comuzzie, AG ;
Allison, DB .
SCIENCE, 1998, 280 (5368) :1374-1377
[4]   EXPRESSION OF THE DIFFERENTIATION-INDUCED GENE FOR FATTY ACID-BINDING PROTEIN IS ACTIVATED BY GLUCOCORTICOID AND CAMP [J].
COOK, JS ;
LUCAS, JJ ;
SIBLEY, E ;
BOLANOWSKI, MA ;
CHRISTY, RJ ;
KELLY, TJ ;
LANE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :2949-2953
[5]  
FOSTER DW, 1994, HARRISONS PRINCIPLES, P2131
[6]   Environmental contributions to the obesity epidemic [J].
Hill, JO ;
Peters, JC .
SCIENCE, 1998, 280 (5368) :1371-1374
[7]  
HIMMSHAGEN J, 1998, HDB OBESITY, P415
[8]   CARDIAC AND ADIPOSE-TISSUE ABNORMALITIES BUT NOT DIABETES IN MICE DEFICIENT IN GLUT4 [J].
KATZ, EB ;
STENBIT, AE ;
HATTON, K ;
DEPINHO, R ;
CHARRON, MJ .
NATURE, 1995, 377 (6545) :151-155
[9]   Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity [J].
Kopecky, J ;
Clarke, G ;
Enerback, S ;
Spiegelman, B ;
Kozak, LP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2914-2923
[10]   DEVELOPMENT OF OBESITY IN TRANSGENIC MICE AFTER GENETIC ABLATION OF BROWN ADIPOSE-TISSUE [J].
LOWELL, BB ;
SSUSULIC, V ;
HAMANN, A ;
LAWITTS, JA ;
HIMMSHAGEN, J ;
BOYER, BB ;
KOZAK, LP ;
FLIER, JS .
NATURE, 1993, 366 (6457) :740-742